Emergency physicians' prescribing of asthma controller medications

Pediatrics

Volumn 117, Issue 3, 2006, Pages 821-827

  Scarfone, Richard J ^a,b   Zorc, Joseph J ^a,b   Angsuco, Cherrie J ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Asthma; Emergency department; Long term controller medication

Indexed keywords

ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CROMOGLYCATE DISODIUM; FLUTICASONE PROPIONATE PLUS SALMETEROL; MONTELUKAST; NEDOCROMIL; SALMETEROL; SALMETEROL XINAFOATE; THEOPHYLLINE; ZAFIRLUKAST; ZILEUTON;

ADOLESCENT; ARTICLE; ASTHMA; CONTROLLED STUDY; EMERGENCY PHYSICIAN; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEDICAL SOCIETY; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT; ACUTE DISEASE; DRUG UTILIZATION; EMERGENCY HEALTH SERVICE; EMERGENCY MEDICINE; EPIDEMIOLOGY; PRIMARY HEALTH CARE;

ACUTE DISEASE; ADOLESCENT; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD, PRESCHOOL; DRUG UTILIZATION; EMERGENCY MEDICINE; EMERGENCY SERVICE, HOSPITAL; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HUMANS; PRESCRIPTIONS, DRUG; PRIMARY HEALTH CARE;

EID: 33645031310     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-0962     Document Type: Article

References (34)

1. Mannino DM, Homa DM, Pertowski CA, et al. Surveillance for asthma: United States, 1960-1995. MMWR CDC Surveill Summ. 1998;47:1-28
2. Centers for Disease Control and Prevention. Asthma mortality and hospitalization among children and young adults: United States, 1980-1993. JAMA. 1996;275:1535-1537
3. Newacheck PW, Halfon N. Prevalence, impact, and trends in childhood disability due to asthma. Arch Pediatr Adolesc Med. 2000;154:287-293
4. Weiss KB, Sullivan SD, Lyttle CS. Trends in the cost of illness for asthma in the United States, 1985-1994. J Allergy Clin Immunol. 2000;106:493-499
5. National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health; 1997. National Institutes of Health Publication 98-4051
6. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma: Update on Selected Topics 2002. Bethesda, MD: National Institutes of Health; 2002. National Institutes of Health Publication 02-5075
7. Thomas JA, Potter MW, Counselman FL, et al. Emergency physician practice and steroid use in the management of acute exacerbations of asthma. Am J Emerg Med. 2001;19:465-468
8. Lieu TA, Quesenberry CP, Capra AM, Sorel ME, Martin KE, Mendoza GR. Outpatient management practices associated with reduced risk of pediatric asthma hospitalization and emergency department visits. Pediatrics. 1997;100:334-341
9. Donahue JG, Weiss ST, Livingston JM, Goetsch MA, Greineder DK, Platt R. Inhaled steroids and the risk of hospitalization for asthma. JAMA. 1997;277:887-391
10. Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med. 2000;343:1054-1063
11. Adams RJ, Fuhlbrigge A, Finkelstein JA, et al. Impact of inhaled antiinflammatory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics. 2001;107:706-711
12. Leickly FE, Wade SL, Crain E, Kruszon-Moran D, Wright EC, Evans R. Self-reported adherence, management behavior, and barriers to care after an emergency department visit by inner city children with asthma. Pediatrics. 1998;101(5). Available at: www.pediatrics.org/cgi/content/ full/101/5/e8
13. Zorc JJ, Scarfone RJ, Li Y, et al. Scheduled follow-up after an emergency department visit for asthma: a randomized trial. Pediatrics. 2003;111:495-502
14. Singh AK, Woodruff PG, Ritz RH, et al. Inhaled corticosteroid for asthma: are ED visits a missed opportunity for prevention? Am J Emerg Med. 1999;17:144-147
15. Finklestein JA, Lozano P, Farber HJ, et al. Underuse of controller medications among Medicaid-insured children with asthma. Arch Pediatr Adolesc Med. 2002;156:562-567
16. Rowe B, Bota GW, Fabris L, et al. Inhaled budesonide in addition to oral corticosteriods to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial. JAMA. 1999;281:2119-2126
17. Sin DD, Man SFP. Low-dose inhaled corticosteroid therapy and risk of emergency department visits for asthma. Arch Intern Med. 2002;162:1591-1595
18. Knorr B, Matz J, Bernstein J, et al. Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trail. JAMA. 1998;279:1181-1186
19. Suissa S, Ernst P, Benayoun S, et al. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000;343:332-336
20. Bisgaard H, Allen D, Milanowski J, et al. Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing. Pediatrics. 2004;113(2). Available at: www.pediatrics.org/cgi/content/full/113/2/e87
21. Peden DB, Berger WE, Noonan MJ, et al. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma. J Allergy Clin Immunol. 1998;102:32-38
22. Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med. 2000;343:1064-1069
23. Baker JW, Mellon M, Wald J, et al. A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants. Pediatrics. 1999;103:414-421
24. Kavuru M, Melamed J, Gross G, et al. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2000;105:1108-1116
25. Brenner BE, Chavda KK, Camargo CA Jr. Randomized trial of inhaled flunisolide versus placebo among asthmatic patients discharged from the emergency department. Ann Emerg Med. 2000;36:417-426
26. Rowe BH, Edmonds ML. Inhaled corticosteroids for acute asthma after emergency department discharge. Ann Emerg Med. 2000;36:477-480
27. Scarfone RJ, Zorc JJ, Capraro GC. Patient self-management of acute asthma: adherence to national guidelines a decade later. Pediatrics. 2001;108:1332-1338
28. Halterman JS, Align CA, Auinger P, McBride JT, Szilagyi PG. Inadequate therapy for asthma among children in the United States. Pediatrics. 2000;105:272-276
29. Warman KL, Silver EJ, McCourt MP, Stein REK. How does home management of asthma exacerbations by parents of inner-city children differ from NHLBI guideline recommendations? Pediatrics. 1999;103:422-427
30. Diaz T, Sturm T, Matte T, et al. Medication use among children with asthma in East Harlem. Pediatrics. 2000;105:1188-1194
31. Cabana MD, Ebel BE, Cooper-Patrick L, Powe NR, Rubin HR, Rand CS. Barriers pediatricians face when using asthma practice guidelines. Arch Pediatr Adolesc Med. 2000;154:685-693
32. Pathman DE, Konrad TR, Freed GL. The awareness-to-adherence model of the steps to clinical guideline compliance: the case of pediatric vaccine recommendations. Med Care. 1996;34:873-889
33. Singer AJ, Camargo CA Jr, Lampell M, et al. A call for expanding the role of the emergency physician in the care of patients with asthma. Ann Emerg Med. 2005;45:295-298
34. Rowe BH, Majumdar SR. Improving quality of asthma care after emergency department discharge: evidence before action. Ann Emerg Med. 2005;45:299-301